175 related articles for article (PubMed ID: 37417559)
1. Effect of decreased renal function on poor oncological outcome after radical cystectomy.
Kim D; Nam W; Kyung YS; You D; Jeong IG; Hong B; Hong JH; Ahn H; Lim B
Investig Clin Urol; 2023 Jul; 64(4):346-352. PubMed ID: 37417559
[TBL] [Abstract][Full Text] [Related]
2. Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer.
Matsumoto A; Nakagawa T; Kanatani A; Ikeda M; Kawai T; Miyakawa J; Taguchi S; Naito A; Otsuka M; Nakanishi Y; Suzuki M; Koga F; Nagase Y; Kondo Y; Okaneya T; Tanaka Y; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
World J Urol; 2018 Feb; 36(2):249-256. PubMed ID: 29185045
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Preoperative Severe Renal Insufficiency on Poor Postsurgical Oncological Prognosis in Patients with Urothelial Carcinoma.
Momota M; Hatakeyama S; Tokui N; Sato T; Yamamoto H; Tobisawa Y; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Narita S; Kawaguchi T; Ohyama C
Eur Urol Focus; 2019 Nov; 5(6):1066-1073. PubMed ID: 29548907
[TBL] [Abstract][Full Text] [Related]
4. Eligibility for neoadjuvant/adjuvant cisplatin-based chemotherapy among radical cystectomy patients.
Thompson RH; Boorjian SA; Kim SP; Cheville JC; Thapa P; Tarrel R; Dronca R; Costello B; Frank I
BJU Int; 2014 May; 113(5b):E17-21. PubMed ID: 24006893
[TBL] [Abstract][Full Text] [Related]
5. Survival of Patients with Chronic Kidney Disease Treated with Radical Cystectomy and Risk Factors of Glomerular Filtration Rate Loss Following Radical Cystectomy: Two Systematic Reviews and Meta-analyses of Interplay Between Radical Cystectomy and Renal Function.
Sari Motlagh R; Ghoreifi A; Yanagisawa T; Kawada T; Kikic Z; Gill I; Daneshmand S; Djaladat H; Shariat SF
Eur Urol Focus; 2024 Jan; 10(1):169-181. PubMed ID: 37442723
[TBL] [Abstract][Full Text] [Related]
6. The effect of urinary diversion on long-term kidney function after cystectomy.
Faraj KS; Mi L; Eversman S; Singh R; DeLucia NM; Blodgett G; Swanson SK; Andrews PE; Ferrigni RG; Humphreys MR; Castle EP; Tyson MD
Urol Oncol; 2020 Oct; 38(10):796.e15-796.e21. PubMed ID: 32482512
[TBL] [Abstract][Full Text] [Related]
7. Long-term renal function in patients with chronic kidney disease following radical cystectomy and orthotopic neobladder.
Ahmadi H; Reddy S; Nguyen C; Douglawi A; Ladi-Seyedian S; Roberts S; Ghoreifi A; Ghodoussipour S; Bhanvadia SK; Djaladat H; Schuckman A; Daneshmand S
BJU Int; 2022 Aug; 130(2):200-207. PubMed ID: 35044045
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of radical cystectomy in ESDR patients with bladder urothelial carcinoma.
Tseng SF; Chuang YC; Yang WC
Int Urol Nephrol; 2011 Dec; 43(4):1067-71. PubMed ID: 21516473
[TBL] [Abstract][Full Text] [Related]
9. Renal function change after radical cystectomy for urothelial carcinoma patients with a solitary kidney may be independent of urinary diversion type.
Kim GH; Yuk HD; Jeong CW; Kwak C; Ku JH
Investig Clin Urol; 2023 Sep; 64(5):457-465. PubMed ID: 37668201
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of postoperative loss in psoas major muscle and nutrition index after radical cystectomy for patients with urothelial carcinoma of the bladder.
Miyake M; Morizawa Y; Hori S; Marugami N; Shimada K; Gotoh D; Tatsumi Y; Nakai Y; Inoue T; Anai S; Torimoto K; Aoki K; Tanaka N; Fujimoto K
BMC Cancer; 2017 Mar; 17(1):237. PubMed ID: 28359307
[TBL] [Abstract][Full Text] [Related]
11. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
[TBL] [Abstract][Full Text] [Related]
12. Performance status as a significant prognostic predictor in patients with urothelial carcinoma of the bladder who underwent radical cystectomy.
Hinata N; Miyake H; Miyazaki A; Nishikawa M; Tei H; Fujisawa M
Int J Urol; 2015 Aug; 22(8):742-6. PubMed ID: 25988857
[TBL] [Abstract][Full Text] [Related]
13. Recurrence patterns of bladder transitional cell carcinoma after radical cystectomy.
Kim B; Choi HJ; Kim MH; Cho KS
Acta Radiol; 2012 Oct; 53(8):943-9. PubMed ID: 22893727
[TBL] [Abstract][Full Text] [Related]
14. The impact of histological variants on outcomes after open radical cystectomy for muscle-invasive urothelial bladder cancer: results from a single tertiary referral centre.
Naspro R; Finati M; Roscigno M; Pellucchi F; La Croce G; Sodano M; Manica M; Chinaglia D; Da Pozzo LF
World J Urol; 2021 Jun; 39(6):1917-1926. PubMed ID: 32696127
[TBL] [Abstract][Full Text] [Related]
15. Impact of statin use on oncologic outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy.
da Silva RD; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Chade D; Guglielmetti GB; Pycha A; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Zerbib M; Scherr DS; Shariat SF
J Urol; 2013 Aug; 190(2):487-92. PubMed ID: 23395802
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological features of recurrence after radical cystectomy for patients with transitional cell carcinoma of the bladder.
Harada K; Sakai I; Kurahashi T; Muramaki M; Yamanaka K; Hara I; Eto H; Miyake H
Int Urol Nephrol; 2006; 38(1):49-55. PubMed ID: 16502052
[TBL] [Abstract][Full Text] [Related]
17. Preoperative chemotherapy for prostatic stromal invasive urothelial bladder cancer: comparison of oncological outcomes of male patients with cT4a disease undergoing radical cystectomy with or without preoperative chemotherapy.
Chen J; Miranda G; Cai J; Daneshmand S; Djaladat H
Scand J Urol; 2019; 53(2-3):123-128. PubMed ID: 31081431
[No Abstract] [Full Text] [Related]
18. Comparison of laparoscopic and open radical cystoprostatectomy for localized bladder cancer with 3-year oncological followup: a single surgeon experience.
Hemal AK; Kolla SB
J Urol; 2007 Dec; 178(6):2340-3. PubMed ID: 17936813
[TBL] [Abstract][Full Text] [Related]
19. Impact of body mass index on the oncological outcomes of patients treated with radical cystectomy for muscle-invasive bladder cancer.
Dabi Y; Rouscoff Y; Anract J; Delongchamps NB; Sibony M; Saighi D; Zerbib M; Peyraumore M; Xylinas E
World J Urol; 2017 Feb; 35(2):229-235. PubMed ID: 27272203
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer Patients With Diminished Renal Function.
Koshkin VS; Barata PC; Rybicki LA; Zahoor H; Almassi N; Redden AM; Fergany AF; Kaouk J; Haber GP; Stephenson AJ; Ornstein MC; Gilligan T; Garcia JA; Rini BI; Grivas P
Clin Genitourin Cancer; 2018 Aug; 16(4):e879-e892. PubMed ID: 29576445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
